BioPharm International
October 01, 2013
Global Report
26
10
The pharmaceutical industry grows despite conflict in the Middle East.
October 01, 2013
Perspectives on Outsourcing
26
10
Practicality of implementation should be a part of vision in the bio/pharmaceutical industry.
October 01, 2013
Special Section
26
10
A twin-column periodic countercurrent capture process that combines an efficient sequential, countercurrent loading process with a minimal twin-column hardware configuration is described.
October 01, 2013
Guest Editorial
26
10
Through its educational and networking opportunities, the American Association of Pharmaceutical Scientists plays an important role in partnering throughout the drug- development and commercialization process.
October 01, 2013
Regulatory Beat
26
10
Manufacturing standards are considered key to preventing drug recalls and shortages.
October 01, 2013
Cover Story
26
10
The authors review the angiopoietin pathway as an alternative for safer and more efficacious anti-angiogenic therapeutics.
October 01, 2013
Global Report
26
10
Foreign companies zero in on Myanmar with the hope of securing a foothold in its pharmaceutical market.
October 01, 2013
Compliance Notes
26
10
By embracing efficiency and quality, biopharmaceutical organizations can work better and achieve better work.
October 01, 2013
Burrill on Biotech
26
10
Early-stage companies are now embraced by buyers of new issues.
October 01, 2013
Analytical Best Practices
26
10
A well-designed comparability study can demonstrate the performance and advantages that can be gained when adopting a new protocol.
October 01, 2013
Peer-Reviewed Research
26
10
The correlation between limulus amebocyte lysate (LAL) assay and rabbit pyrogen test (RPT) targeting recombinant human epidermal growth factor (rhEGF) as active molecule was assessed.
October 01, 2013
Issue PDF
26
10
Click the title above to open the BioPharm International October 2013 issue in an interactive PDF format.